Evidence map›Paper›PMID 29867944›Full record

ArticleFrontiers in immunology2018

The Classical Complement Pathway Is Required to Control

Hui Zhi, Jialei Xie, Jon T Skare

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Protective efficacy of mutant strains ofInfection and immunity · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Survival ofPathogens (Basel, Switzerland) · 2024
    Article
  8. Comparative reservoir competence ofApplied and environmental microbiology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Lyme Disease Pathogenesis.Current issues in molecular biology · 2021
    Review
  19. Lyme Disease in Humans.Current issues in molecular biology · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Hui ZhiDepartment of Microbial Pathogenesis and Immunology, College of Medicine, Texas A&M Health Science Center, Bryan, TX, United States.
Jialei XieDepartment of Microbial Pathogenesis and Immunology, College of Medicine, Texas A&M Health Science Center, Bryan, TX, United States.
Jon T SkareDepartment of Microbial Pathogenesis and Immunology, College of Medicine, Texas A&M Health Science Center, Bryan, TX, United States.
Texas A&M Health Science Center · US

Funding

Host Spirochete Interactions in Lyme DiseaseR01AI058086 · NIAID · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI SKARE, JON T · 2006 to 2010
$1.8M
Collagen binding as a virulence mechanism in Lyme borreliosisR21AI119821 · NIAID · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI HOOK, AXEL MAGNUS, SKARE, JON T · 2015 to 2016
$400k
NIAID NIH HHS R01 AI058086NIAID NIH HHS R21 AI119821
6 · The paper itself

Abstract

Activation of the classical complement pathway occurs to varying degrees within strains of the

Indexed as

AnimalsAntibodies, BacterialBorrelia burgdorferiComplement C1qComplement Pathway, ClassicalCytokinesHeartImmunoglobulin Class SwitchingImmunoglobulin GImmunoglobulin MLuminescent MeasurementsLyme DiseaseMiceMice, Inbred C57BLMice, KnockoutPolymerase Chain ReactionAntibodies, BacterialComplement C1qCytokinesImmunoglobulin GImmunoglobulin MBorrelia burgdorferiC1qcomplement system proteinsinnate immunityspirochetes

Identifiers

PMID29867944
PMCPMC5949333
OpenAlexW2801643542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.